198
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Correlates of spontaneous clearance of hepatitis C virus in a Danish human immunodeficiency virus type 1 cohort

, , , , , & show all
Pages 798-803 | Received 25 Feb 2011, Accepted 12 May 2011, Published online: 05 Jul 2011

References

  • Jacobson IM, Davis GL, El-Serag H, Negro F, Trepo C. Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection. Clin Gastroenterol Hepatol 2010;8:924–33.
  • Hoofnagle JH. Course and outcome of hepatitis C. Hepatology 2002;36:S21–9.
  • Zhang M, Rosenberg PS, Brown DL, Preiss L, Konkle BA, Eyster ME, . Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia. Blood 2006;107:892–7.
  • Sulkowski MS. Viral hepatitis and HIV coinfection. J Hepatol 2008;48:353–67.
  • Bruno R, Sacchi P. Spontaneous hepatitis C virus clearance in HIV-infected patients: new insights for improving management. J Infect Dis 2008;198:1262–4.
  • Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, . The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000;284:450–6.
  • Soriano V, Mocroft A, Rockstroh J, Ledergerber B, Knysz B, Chaplinskas S, . Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe. J Infect Dis 2008;198:1337–44.
  • Hansen N, Obel N, Christensen PB, Krarup H, Laursen AL, Clausen MR, . Predictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort study. J Viral Hepat 2009;16:659–65.
  • Krarup HB, Drewes AM, Madsen PH. A quantitative HCV-PCR test for routine diagnostics. Scand J Clin Lab Invest 1998;58:415–22.
  • Gottwein JM, Scheel TK, Hoegh AM, Lademann JB, Eugen-Olsen J, Lisby G, . Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses. Gastroenterology 2007;133:1614–26.
  • Pittaluga F, Allice T, Abate ML, Ciancio A, Cerutti F, Varetto S, . Clinical evaluation of the COBAS Ampliprep/COBAS TaqMan for HCV RNA quantitation in comparison with the branched-DNA assay. J Med Virol 2008;80: 254–60.
  • Krarup HB, Moller JM, Christensen PB, Fuglsang T, Ingerslev J, Arnfred T, . Haemophilic patients with hepatitis C have higher viral load compared to other well-defined patient groups. J Viral Hepat 2000;7:435–9.
  • Murphy DG, Willems B, Deschenes M, Hilzenrat N, Mousseau R, Sabbah S. Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5′ untranslated region sequences. J Clin Microbiol 2007;45:1102–12.
  • Nascimbeni M, Mizukoshi E, Bosmann M, Major ME, Mihalik K, Rice CM, . Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees. J Virol 2003;77:4781–93.
  • Kamal SM, Amin A, Madwar M, Graham CS, He Q, Al Tawil A, . Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients. J Virol 2004;78:12252–8.
  • Major ME, Mihalik K, Puig M, Rehermann B, Nascimbeni M, Rice CM, . Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge. J Virol 2002;76:6586–95.
  • Busch MP, Glynn SA, Stramer SL, Orland J, Murphy EL, Wright DJ, . Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors. Transfusion 2006;46:469–75.
  • Deterding K, Tegtmeyer B, Cornberg M, Hadem J, Potthoff A, Boker KH, . Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV. J Hepatol 2006;45:770–8.
  • Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001;19:65–91.
  • Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996;86:655–61.
  • Villano SA, Vlahov D, Nelson KE, Lyles CM, Cohn S, Thomas DL. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J Clin Microbiol 1997;35:3274–7.
  • Nunez M, Soriano V. Hepatitis C virus (HCV) genotypes and disease progression in HIV/HCV-coinfected patients. J Infect Dis 2005;191:1–3.
  • Lehmann M, Meyer MF, Monazahian M, Tillmann HL, Manns MP, Wedemeyer H. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection. J Med Virol 2004;73:387–91.
  • Thomson EC, Fleming VM, Main J, Klenerman P, Weber J, Eliahoo J, . Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men. Gut 2011;60:837–45.
  • McKiernan SM, Hagan R, Curry M, McDonald GS, Kelly A, Nolan N, . Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology 2004;40:108–14.
  • Thio CL, Gao X, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, . HLA-Cw*04 and hepatitis C virus persistence. J Virol 2002;76:4792–7.
  • Rauch A, Kutalik Z, Descombes P, Cai T, di Iulio J, Mueller T, . Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 2010;138:1338–45.
  • Clausen LN, Weis N, Astvad K, Schonning K, Fenger M, Krarup H, . Interleukin-28B polymorphisms are associated with hepatitis C virus clearance and viral load in a HIV-1-infected cohort. J Viral Hepat 2011;18:e66–74.
  • Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, . Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009;461:798–801.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.